logo-loader
viewSirius Minerals PLC

Sirius Minerals shows off latest progress at £4bn Woodsmith fertiliser project

Sirius has given investors, and the public in general, the latest inside look at its fertiliser mine – widely seen as the most ambitious, privately-funded civil engineering project in Europe

tunnel
Work continues on the transport tunnel

Sirius Minerals PLC (LON:SXX) has released flyover videos and images marking the latest progress at its £4bn fertiliser project in North Yorkshire.

The interactive map shows before, after and future images of the works at all of the key locations, including the materials handling facility near Redcar and the Woodsmith mine itself.

WATCH: Take a look at the latest videos and images

There is also a flyover of Lockwood Beck, where Sirius is building a mineral transport system – effectively a 37km-long tunnel which will take the fertiliser from the mine to the processing facilities.

The latest evidence of mine site progress follows on from a short video released last week which showed work continuing on the tunnel at Wilton.

Sirius also gained more publicity last week, when it was mentioned by Theresa May in Prime Minister’s Questions.

The FTSE 250 company is in the process of raising the final US$3.5bn it needs to complete development of the mine and has previously said that a Treasury guarantee, which would see the government underwrite US$2bn of project loans, was “essential” in securing the remaining funding.

“In relation to the particular discussions … these are commercially sensitive so it would be inappropriate for me to comment on the specific discussions, but this is exactly the sort of project that is what the Northern Powerhouse is all about: driving investment, driving exports, good for the north,” May told fellow MPs.

Sirius shares were up 0.5% to 22.5p on Monday morning.

Quick facts: Sirius Minerals PLC

Price: 3.55 GBX

LSE:SXX
Market: LSE
Market Cap: £249.22 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Summit Therapeutics' Glyn Edwards talks US$50mln backing and ridinilazole...

Summit Therapeutics PLC's (LON:SUMM, NASDAQ:SMMT) CEO Glyn Edwards sat down with Proactive London's Andrew Scott following the news of a US$50mln funding deal with biotech billionaire Bob Duggan. The investment will help get the company’s next-generation antibiotic through phase III clinical...

8 hours, 35 minutes ago

2 min read